Prevalence of the JAK2 V617F and MPL Mutations in Stroke, Abdominal and Peripheral Venous Thrombosis

被引:6
|
作者
McCarthy, Niamh [2 ]
McCarron, Sarah L. [1 ]
Langabeer, Stephen E. [1 ]
机构
[1] St James Hosp, Cent Pathol Lab, Dublin 8, Ireland
[2] St James Hosp, Dept Haematol, Dublin 8, Ireland
关键词
CHRONIC MYELOPROLIFERATIVE DISORDERS; BUDD-CHIARI-SYNDROME; NEOPLASMS; DIAGNOSIS; JAK2V617F;
D O I
10.1159/000320171
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:160 / 161
页数:2
相关论文
共 50 条
  • [21] Detection of V617F mutation of JAK2 gene by high resolution melting
    Quintana, Silvina
    Schoenfeld, Erika
    Di Geronimo, Vanesa
    Martin, Nazarena
    Pagani, Fernando
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2014, 48 (04): : 447 - 455
  • [22] Polycythemia Vera and the Jak2(V617F) Mutation in a Case of Hereditary Spherocytosis
    Fleischman, Roger A.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2013, 346 (04) : 328 - 330
  • [23] A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation
    Tan, Angela Y. C.
    Westerman, David A.
    Dobrovic, Alexander
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (06) : 977 - 981
  • [24] Janus kinase (JAK) 2 V617F mutation in Asian Indians with cerebral venous thrombosis and without overt myeloproliferative disorders
    De, Tanima
    Prabhakar, Puttachandra
    Nagaraja, Dindagur
    Christopher, Rita
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2012, 323 (1-2) : 178 - 182
  • [25] The prevalence of the JAK2 V617F Exon 14 mutation in Sudanese patients with Myelo Proliferative Neoplasms (MPNs)
    Yasin, Elrashed B.
    Kordofani, Anwaar A. Y.
    Elamin, Bahaeldin K.
    Dallol, A.
    BIOSCIENCE RESEARCH, 2019, 16 (03): : 2423 - 2429
  • [26] Toward point-of-care testing for JAK2 V617F mutation on a microchip
    Wang, Hua
    Liu, Weiwei
    Zhang, Xinju
    Xu, Xiao
    Kang, Zhihua
    Li, Shibao
    Wu, Zhiyuan
    Yang, Zhiliu
    Yao, Bo
    Guan, Ming
    JOURNAL OF CHROMATOGRAPHY A, 2015, 1410 : 28 - 34
  • [27] Splanchnic venous thrombosis in JAK2 V617F mutation positive myeloproliferative neoplasms - long term follow-up of a regional case series
    Greenfield, Graeme
    McMullin, Mary Frances
    THROMBOSIS JOURNAL, 2018, 16
  • [28] Megakaryocytic Morphology and Clinical Parameters in Essential Thrombocythemia, Polycythemia Vera, and Primary Myelofibrosis With and Without JAK2 V617F
    Vytrva, Nataliya
    Stacher, Elvira
    Regitnig, Peter
    Zinke-Cerwenka, Wilma
    Hojas, Sabine
    Hubmann, Eva
    Porwit, Anna
    Bjorkholm, Magnus
    Hoefler, Gerald
    Beham-Schmid, Christine
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2014, 138 (09) : 1203 - 1209
  • [29] Morphologic and Molecular Characteristics of De Novo AML With JAK2 V617F Mutation
    Hidalgo-Lopez, Juliana E.
    Kanagal-Shamanna, Rashmi
    Medeiros, L. Jeffrey
    Estrov, Zeev
    Yin, C. Cameron
    Verstovsek, Srdan
    Konoplev, Sergej
    Jorgensen, Jeffrey L.
    Mohammad, M. Mohammad
    Miranda, Roberto N.
    Zhao, Chong
    Lee, John
    Zuo, Zhuang
    Bueso-Ramos, Carlos E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (06): : 790 - 796
  • [30] Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations
    Turakhia, Samir K.
    Murugesan, Gurunathan
    Cotta, Claudiu V.
    Theil, Karl S.
    JOURNAL OF CLINICAL PATHOLOGY, 2016, 69 (08) : 713 - 719